.
Current knowledge of the biological effects of these new IL-10-type cytokines is sparse. They seem to be mainly produced by cells of lymphoid or myeloid origin (3, 5) , but keratinocytes and other epithelial cells may also be a source for IL-19, IL-20, and IL-24 (6) . There is strong evidence that IL-20 and possibly also IL-19 and IL-24 are implicated in psoriasis because their expression increases with progression of the disease. IL-20 up-regulates inflammatory genes such as chemokines, proteases, and defensins in the skin (7) (8) (9) . Epidermal hyperplasia was inhibited in an IL-23-dependent psoriasis mouse model when IL-20R2 signaling was missing (10) .
IL-20 was detected in synovial fluids of patients with rheumatoid arthritis (11) , and it may participate in the development of atherosclerosis. rIL-20 and rIL-24 might promote angiogenesis (12, 13) . IL-19 was reported to up-regulate Th2 cytokines in an animal model of asthma (14) . The mechanisms regarding how IL-19, IL-20, and IL-24 influence the pathogenesis of immunological driven diseases are not conclusively resolved. Quantitative analysis of the RNA expression of their receptor chains suggests that stroma/parenchymal cells are the major targets of these cytokines (5, 15, 16) .
Given their immune cell origins, these cytokines thus may be candidates for cross-talk between resident parenchymal cells of various organs with tissue-infiltrating leukocytes, monocytes, and APCs. Signaling of their receptors in immune cells has not been clearly demonstrated. In comparison with the high expression levels of IL-20R1, IL-22R, and IL-20R2 mRNA in some parenchymal cells (e.g., skin), their constitutive mRNA levels in lymphoid cells are low (5, 15) . High-affinity Abs specific for the receptor chains are not yet available. Nevertheless, recent in vitro studies allow the presumption that these cytokines have Th2-polarizing effects on cultured naive T lymphocytes (17) and are able to induce IL-10 in macrophages and dendritic cells (DCs) 4 (18) . Several reports showed functional effects of rIL-19, rIL-20, and rIL-24 on immune cells (19, 20) . To date, functional studies relied on the use of rIL-10-type cytokines over a longer stimulation period (17) . Thus, unwanted side effects due to impurities of the cytokine preparations could not be excluded. Summarizing the above, it is still controversial whether lymphocytes are targets for IL-19, IL-20, or IL-24.
The closely related cytokine IL-22 binds to a heterodimeric receptor complex consisting of IL-22R and IL-10R2 chains. Recent reports show that IL-22 strengthens innate immune responses, for example, of keratinocytes, hepatocytes, and colonic epithelial cells. There is growing evidence that IL-22 does not act on immune cells, but has important functions in innate tissue defense mechanisms (21) (22) (23) .
To analyze the effects of IL-19, IL-20, and IL-24 on T cells in vitro and on specific Ag-dependent immune responses in vivo, we generated a knockout mouse with a genomic deletion of the first exon of IL-20R2. Because IL-20R2 is the common receptor subunit for this group of cytokines, we were able to analyze adaptive immune responses in vivo and in vitro, when signaling of all three cytokines is missing. For the first time, we provide evidence that IL-20R2 modulates the T cell phenotype after activation in vivo and in vitro. In this study, we show that IFN-␥ and IL-2 secretion is elevated after stimulation of IL-20R2 Ϫ/Ϫ -deficient CD8 and CD4 T cells in vitro. In addition, IL-10 secretion by cultured IL-20R2 Ϫ/Ϫ CD4 cells was diminished. We found that IL-20R2 enhances specific T cell responses to locally (i.m. or intradermal (i.d.)) applied DNA vaccines in vivo. Primary and secondary CD8 T cell responses to Ag were 2-to 3-fold higher in IL-20R2 Ϫ/Ϫ mice than in IL-20R2 ϩ/Ϫ mice. In a T cell-dependent model of contact hypersensitivity (CHS), knockout mice showed an increased response upon elicitation with the contact allergen trinitrochloro-benzene (TNCB). Thus, the cytokines IL-19, IL-20, and IL-24 act directly on CD8 and CD4 T cells and attenuate the development of specific CD8 T cell responses to DNA vaccines and contact allergens.
Materials and Methods

Animals
C57BL/6J (B6), BALB/cJ, OT I-Rag Ϫ/Ϫ , OT II-Rag Ϫ/Ϫ (The Jackson Laboratory), and IL-20R2 Ϫ/Ϫ mice were kept under standard pathogen-free conditions in the animal colonies of Ulm University. Male and female mice were used at 8 -14 wk of age. All animals received humane care. Animal experiments were approved by a state-appointed board on animal ethics and were performed according to international guidelines of animal experimentation.
Knockout construct and generation of IL-20R2
Ϫ/Ϫ mice A 9-kb genomic fragment of the IL-20R2 gene was generated by PCR (genomic DNA of mouse strain 129 Ola) and sequenced, and the sequence was confirmed by data bank analysis. Mapping of the transcriptional start of the IL-20R2 gene by RACE as well as expressed sequence tag (EST) searches gave no hints for an alternative exon 1 (data not shown). 
RT-PCR
RNA was prepared from spleen, liver, or T cells using the RNAeasy mini kit (Qiagen). Genomic DNA was removed with DNase (Qiagen). A total of 2 g of RNA was reverse transcribed using SuperScript reverse transcriptase, according to the manufacturer's instructions (Invitrogen). Primers are listed in Table I and Ref. 24 . The housekeeping gene cyclophilin (24) or commercially available primers from (RT 2 PCR primers; SABiosciences) for the housekeeping genes mHprt1 or m␤-actin were used to equalize cDNA amounts between preparations. Quantitative and semiquantitative PCR was performed, as described previously (24) .
Cytokines and serum protein and Ab levels
Cytokines in supernatants were either detected by conventional doublesandwich ELISA (IL-2, IFN-␥, IL-10) using detection and capture Abs from BD Biosciences, as described (25) , or by flow cytometry (Fluorikine xMAP Technology, on workstations with Luminex IS Software v2.3). For conventional ELISAs, extinction was measured at 405/490 nm on a TECAN microplate-ELISA reader (TECAN) using the EasyWin software (TECAN). For quantification of cytokines from cell culture supernatants, a mouse cytokine 20-plex assay kit (Invitrogen) was conducted per manufacturer's instructions. Cytokine 20-plex assays were analyzed on a Luminex 100 LiquiChip Workstation (Qiagen), and the data were analyzed using LiquiChip Analyzer software v1.0.2. IFN-␥, IL-10, IL-4, IL-5, and IL-13 concentrations were further confirmed with Fluorokine MAP mouse cytokine kits from R&D Systems. ELISAs were analyzed on BioPlex 200 Workstation (Bio-Rad) with Bioplex Manager Software 4.1 (Bio-Rad). For the quantification of Igs in serum, suspension arrays based on xMAP technology were conducted in principle, as described above and published previously (26) . In addition, IgE levels determined by xMAP assays were verified by a conventional ELISA (BioLegend). All xMAP assay measurements were conducted for a minimum of 100 beads. Statistical significance of differences in Ig and cytokine concentrations was analyzed using the Mann-Whitney U test. Values of p Ͻ 0.05 ‫)ء(‬ were considered statistically significant.
DNA vaccines, adjuvants, and immunization of mice
LPS (Escherichia coli K235; Sigma-Aldrich) was dissolved in PBS, and mice were injected i.p. with 5 mg/kg. The hepatitis B surface Ag (HBsAg)-encoding fragment of hepatitis B virus (subtype ayw) was cloned into pCI vector (Promega). The complete OVA coding sequence was cloned into . Sequences are written from 5Ј nucleotide position (left) to 3Ј nucleotide position (right) of the source sequence. Reference sequence: mIL-20R2, NM_001033543; mIL-6, NM_031168. In addition to cyclophilin (24) (NT_03947624), commercially available primers (SABiosciences) for the housekeeping genes m␤ actin (NM_007393) and Hprt1 (NM_013556) were used to equalize cDNA amounts between preparations. Q-PCR was performed as described previously (24) . pCI/S. The Ag sequence in the resulting pCI/S and pCI/OVA vectors is under the control of the CMV immediate early promoter (27) .
The i.m. nucleic acid immunization was achieved by injecting 50 g (1 g/ml) of plasmid DNA into each tibialis muscle, as described previously (28) . Intradermal injection of 2 g of particle-loaded DNA with the Helios gene gun system (Bio-Rad) was performed as described (27) . Mice were vaccinated once and analyzed at day 12. For boost experiments, mice received a second application of vaccine at day 30 after priming and were analyzed at day 42.
Preparation of cells, T cell culture, coculture, and growth response
Spleens were removed and passed through a metal mesh to obtain single-cell suspensions. Erythrocytes were lysed in NH 4 Cl buffer (0.14 M NH 4 Cl and 0.17 M Tris (pH 7.2)). After washing, spleen cells were cultured in 200 l of round-bottom microwells in RPMI 1640 medium supplemented with 5% FCS, 2 mM L-glutamine, and antibiotics, or used for further purification steps. CD4/CD8 T cells were isolated by MACS (negative selection; Miltenyi Biotec) exactly as described by the supplier. Purity of T cells was analyzed by flow cytometry (FCM) analysis and was greater than 98%. T cells (2 ϫ 10 5 ) were cultured in roundbottom microwells in 200 l of RPMI 1640 medium supplemented with 5% FCS, 2 mM L-glutamine, and antibiotics. Con A (Sigma-Aldrich) or anti-CD3/CD28 beads (Dynabeads; Invitrogen) were added 1 h after preparation. Con A was added to cell cultures at 1 g/ml, and anti-CD3/CD28 beads were adjusted to one bead/cell, unless described otherwise in the figure legend.
Thymidine incorporation assay was performed to follow growth of T cells. A total of 1 ϫ 10 5 cells/well was cultured in flat-bottom 200-l wells. Cells were pulsed for 6 h with 1 Ci/well 
Determination of intracellular cytokines and specific T cell frequencies by FCM
CD8 cell frequencies. Spleen cells (1 ϫ 10 7 /ml) were incubated for 4 h in RPMI 1640 medium with 1 g/ml K b /S 190-197 VWLSVIWM or K b OVA 257-264 SIINFEKL or nonspecific control peptides, as described (25) . After 1 h, brefeldin A (BFA) was added. For determination of CD4 frequencies, spleen cells were stimulated ex vivo with rHBsAg (10 g/ml) (25) . After 20 h, BFA (2.5 g/ml) was added for 4 h. Cells were harvested and surface stained with PE-conjugated anti-CD8 mAb (BD Pharmingen) or anti-CD4 mAb (BD Biosciences). Surface-stained cells were fixed with 2% paraformaldehyde in PBS before intracellular staining for IFN-␥. Fixed cells were resuspended in permeabilization buffer (HBSS, 0.5% BSA, 0.5% saponin, and 0.05% sodium azide), incubated with FITC-conjugated anti-IFN-␥ (or anti-TNF) mAb (BD Pharmingen) for 30 min at room temperature, and washed twice in permeabilization buffer. Stained cells were resuspended in PBS supplemented with 0.3% (w/v) BSA and 0.1% (w/v) sodium azide. Numbers of CD4 or CD8 IFN-␥ ϩ T cells per 10 5 splenic CD8 T cells were determined by FACS.
Alternatively, freshly isolated cells were washed twice with FACS buffer (PBS/0.3% w/v BSA and 0.1% w/v sodium azide). Total Agspecific CD8 T cell frequencies in spleen cells (1 ϫ 10 7 /ml) were detected by tetramer staining after blocking of unspecific binding of Abs to FcRs with mAb 2.4G2 directed against FC␥RIII/IICD 16/CD32 (0.5 g of Abs/10 6 cells/100 l). Cells were then incubated with allophycocyanin-conjugated CD8 or CD4 mAb (BD Biosciences) and PE-conjugated tetramers K b /S 190-197 VWLSVIWM or K b /OVA 257-268 SIINFEKL (provided by the tetramer facility of National Institute of Allergy and Infectious Diseases) for 30 min at 4°C. Cells were washed twice in FACS buffer and analyzed by FCM, as described (25) . Briefly, cells were washed twice and FcRs were blocked with mAb 2.4G2 (BD Biosciences) to prevent unspecific binding of Abs. Cells were washed and incubated with the relevant Abs for 30 min at 4°C and washed twice. FCM was performed by FACSCalibur (BD Biosciences). The forward narrow angular light scatter was used as an additional parameter to facilitate exclusion of dead cells and aggregated cell clumps. Data were analyzed using the WinMDI software.
CHS assay
Induction of CHS was performed, as described previously (30) . In brief, BALB/c IL-20R2 mutant mice or wild-type littermates were painted on their abdominal skin with 100 l of acetone (background reaction) or 7% TNCB in acetone at day 0. On day 5, mice were challenged by painting 10 l of 1% TNCB on both sides of the ears. Ear thickness from left and right ear was measured with an engineer's micrometer (Mitutoyo) before and 24 h after challenge, and ear swelling was calculated.
Statistics
Data were analyzed using the GraphPad Prism software (version 4.0). Values were presented as means Ϯ SD. Unless otherwise stated, at least three animals per group/time point were used in each experiment. Experiments were repeated three times. B6, IL-20R2 ϩ/Ϫ , and IL-20R2 Ϫ/Ϫ mice were always treated in parallel.
Results
Generation of IL-20R2
Ϫ/Ϫ mice
To disrupt the IL-20R2 gene expression, the first exon (Fig. 1A) was deleted by homologous recombination. Successful deletion of the IL-20R2 allele was verified by PCR and Southern blot with specific probes (S) and primers (P) annealing outside of the target sequence (S1, P1) and within the target sequence (S2 and P2, P3) (Fig. 1, B and C) . We showed previously (24) that the IL-20R2 mRNA is up-regulated in the liver after in vivo injection of LPS. This LPS-induced expression of the IL-20R2 mRNA was not detectable by RT-PCR in IL-20R2 Ϫ/Ϫ mice ( Fig. 1D) , showing that the IL-20R2 gene is successfully inactivated in IL-20R2 Ϫ/Ϫ mice. IL-6 ELISA in sera and IL-6 quantitative PCR of liver and spleen of all LPS-injected mice was performed to follow proper induction of the acute-phase reaction (data not shown).
IL-20R2 Ϫ/Ϫ mice revealed no statistically relevant derivations from the normal mendelian inheritance. IL-20R2 Ϫ/Ϫ mice bred and developed normally, without signs of inflammation under normal housing conditions. Histologically, all mice were without pathological abnormalities. Older mice (up to 1 year) are healthy and do not develop tumors. We analyzed the lymphoid cells of spleen, inguinal lymph nodes, nonparenchymal cells from liver, and Peyer's patches by FACS analysis. Absolute numbers of T, NK, NKT, and B cells were comparable between IL-20R2 Ϫ/Ϫ and congenic IL-20R2 ϩ/ϩ or IL-20R2 ϩ/Ϫ mouse strains. We observed no differences in surface markers of immune cells isolated from wild-type and IL-20R2 Ϫ/Ϫ mice. Thus, T and B cell development is normal in IL-20R2 knockout mice. There was also no difference in cell numbers and distribution of APCs (DCs, macrophages) between both mouse strains.
IL-20R2 signaling regulates activation of T cells in vitro
The cytokines IL-19, IL-20, and IL-24 are expressed in T cells (3, 5) , but their action on lympho-or myeloid cells has not been conclusively shown to date. Signaling of all three cytokines is abolished in cells from IL-20R2 Ϫ/Ϫ mice. We therefore tested whether IL-20R2 deficiency influences the activation of spleen cell cultures (containing APC and T cells) by anti-CD3/CD28 and Con A.
Single-cell suspensions of spleens from IL-20R2 ϩ/Ϫ or IL-20R2 Ϫ/Ϫ genotype were prepared. After polyclonal stimulation with Con A or anti-CD3/CD28 beads, spleen cell cultures of IL-20R2 Ϫ/Ϫ mice showed higher IFN-␥ and IL-2 cytokine secretion (Fig. 2, A and B) . (Fig. 3A) . IL-20R2-deficient CD8 cells showed higher proliferation responses than T cells from control animals (Fig. 3B) . Anti-CD3/CD28 bead-activated IL-20R2 Ϫ/Ϫ CD4 cells also produced more IL-2 and IFN-␥ than control CD4 cells (Fig. 4A) . In addition, bead-activated IL-20R2 Ϫ/Ϫ CD4 cells secreted less IL-10 and IL-4 compared with stimulated IL-20R2 ϩ/Ϫ CD4 cells (Fig. 4A) . Quantification of culture supernatants from activated CD4 cells for secretion of the Th2 cytokine IL-5 revealed no difference between both mouse strains. IL-13 was not detectable in culture supernatants of activated IL-20R2 ϩ/ϩ or IL-20R2 Ϫ/Ϫ CD4 T and CD8 T cells (data not shown). The IL-20R2-deficient CD4 cells showed higher proliferation responses than T cells from control animals, as judged by 3 H incorporation assay (Fig. 4B ). FACS analysis (Table II) 
IL-20R2
Ϫ/Ϫ T cells after 3 days of culture shows that cell numbers as well as the proportion of IFN-␥-and IL-2-positive CD4 and CD8 cells are higher in IL-20R2 Ϫ/Ϫ than in IL-20R2 ϩ/ϩ T cell cultures. We found that addition of murine IL (mIL)-20 (Ն250 ng) was sufficient to repress the IFN-␥ secretion of wild-type CD8 and CD4 T cells that were submaximally stimulated (i.e., Ͻ0.5 anti-CD3/ CD28 bead/cell; supplementary data 5 Fig. 1 ). In summary, these data suggest that the enhanced activation of IL-20R2-deficient T cells is intrinsic to the T cell population and may be independent of APC.
We therefore analyzed Ag-dependent T cell priming of IL-20R2 ϩ/Ϫ -and IL-20R2-deficient DCs. Peptide-pulsed DCs of IL-20R2 Ϫ/Ϫ and IL-20R2 ϩ/Ϫ genotypes were cocultured with naive OT I-RAG Ϫ/Ϫ (CD8) (Fig. 5A) or OT II-RAG Ϫ/Ϫ (CD4) T cells (Fig. 5B) .
T cells activated by DCs of wild-type or knockout animals showed no difference in IFN-␥, IL-12p40 (Fig. 5) , and IL-10 (data not shown) cytokine secretion. These results confirm that IL-20R2 signaling most likely down-regulates CD8 and CD4 T cell answers directly. Ag presentation and T cell stimulation by DCs are not influenced by IL-20R2 signaling. Ϫ/Ϫ mice than in control groups (Fig. 6, A and  B) . Thus, IL-19, IL-20, and IL-24 down-modulate CD8 responses to DNA vaccines in vivo, and this effect is not restricted to a single type of Ag. Furthermore, elevated CD8 responses in immunized IL-20R2 Ϫ/Ϫ mice were independent of Ag amount or vaccination route. Intradermal application (gene gun) of low amounts of pCI/S DNA Ag in mice also generated higher Ag-specific CD8 responses in IL-20R2 Ϫ/Ϫ mice than in wild-type mice (data not shown).
IL-20R2 signaling down-regulates T cell answers to DNA vaccination in vivo
Next, CD4 cells from (i.d. or i.m.) vaccinated IL-20R2
Ϫ/Ϫ and IL-20R2 ϩ/Ϫ animals were analyzed. In comparison with control mice, higher levels of IFN-␥-positive CD4 cells/total CD4 cells (Fig. 6C) were recovered from immunized IL-20R2 Ϫ/Ϫ mice. In addition, Ag-restimulated IL-20R2 Ϫ/Ϫ CD4 cells produced less IL-10 than wild-type CD4 cells (data not shown). Hence, the in vitro results confirmed our in vitro observations.
Time course of CD8 cell activation and impact of IL-20R2 signaling on CD8 memory response
We next analyzed the kinetics of CD8 primary response to vaccine and the memory response to Ag in IL-20R2 ϩ/Ϫ and IL-20R2
Ϫ/Ϫ mice. Mice (n ϭ 15) were vaccinated i.m. with pCI/S, and the generation of Ag-specific CD8 cells was analyzed by FACS at the indicated time points (Fig. 7) . A group of these mice received a 5 The online version of this article contains supplementary material. second injection of pCI/S at day 30 (boost). Twelve days after boost, total (tetramer) Ag-specific CD8 T cell numbers were analyzed. The secondary CD8 response to Ag was 2-to 3-fold higher in knockout animals than in heterozygous littermates. The time course shows that CD8 cells were activated with similar kinetics in IL-20R2 Ϫ/Ϫ and IL-20R2 ϩ/Ϫ mouse strains (Fig. 7) . The highest CD8 frequencies were detectable at ϳday 12-14 postvaccination, and specifically activated CD8 cells contracted until day 30 to similar levels in both mouse strains. This suggests that IL-20R2 enhances the primary and secondary response of CD8 cells to Ag, but it does not influence the kinetics of Ag-specific T cell activation, expansion, and subsequent contraction. Thus, the higher memory response in IL-20R2-deficient mice was not due to a longer persistence of CD8 T cells after primary activation.
IL-20R2 signaling aggravates hypersensitivity reaction to TNCB
Sensitization against TNCB is an established murine model to study allergic contact dermatitis. We chose the CHS model to analyze the reaction of IL-20R2 Ϫ/Ϫ mice, because CHS against TNCB depends on the Ag-specific activation of T cells, particularly of CD8 cells (31) . IL-20R2 Ϫ/Ϫ and heterozygous control mice (on BALB/c background, generation 7) were sensitized against the contact allergen TNCB. When challenged with TNCB, IL-20R2-deficient mice showed significantly increased ear-swelling response (n ϭ 8) compared with IL-20R2 ϩ/Ϫ (Fig. 8) . Thus, in vivo signaling of IL-19, IL-20, or IL-24 is important to attenuate the CHS against TNCB. (Fig. 9) . We found no alterations in IgA, IgM IgG2a, IgG2b, and IgG3 levels in C57BL/6 or BALB/c mice of IL-20R2 Ϫ/Ϫ and IL-20R2 ϩ/ϩ genotypes. Basal IgE serum levels of knockout and wild-type mice (n ϭ 12) were also comparable. We next tested whether the induction of IgE is impaired in IL-20R2-deficient mice. IL-20R2 Ϫ/Ϫ and normal littermates (n ϭ 4) were i.p. injected with 200 g of goat anti-mouse IgD that induces IgE (32). Five days after injection, IgE levels of goat anti-mouse IgD-treated knockout mice were as high as in wild-type animals (ELISA, Ϸ800 -1000 ng/ml; data not shown). Thus, there is no general defect of IgE production in IL-20R2-deficient mice.
In some experiments (n ϭ 14 -16, C57BL/6 backgound), IgG1 basal serum levels were moderately higher in IL-20R2 Ϫ/Ϫ mice. We therefore tested in vivo whether the Ab response to Ag is shifted toward a Th1-like isotype response in knockout mice. During Th2-like immune reactions, a lower IgG2a/IgG1 isotype ratio of Ag-specific Abs is generated than in Th1-polarized immune answers (27) . The specific Ab response to HBsAg after vaccination with pCI/S was analyzed in IL-20R2 Ϫ/Ϫ and IL-20R2 ϩ/ϩ littermates. The IgG2a/IgG1 ratio was not changed in knockout mice when compared with vaccinated wild-type littermates (data not shown). With Th2 (i.d., gene gun)-directed vaccination strategies (27) that generate high amounts of IgG1 relative to IgG2a, comparable IgG2a/IgG1 serum responses were mounted in both mouse strains (BALB/c background). Thus, the immune system is not shifted toward a more Th1-like Ab isoprofile (i.e., higher IgG2a/ IgG1 ratio) in IL-20R2 Ϫ/Ϫ mice under noninflammatory conditions used in this study.
Discussion
The new IL-10-type cytokines IL-19, IL-20, IL-22, and IL-24 seem to be involved in diseases that are correlated with pathological changes within the immune system (9, 14, 18, 33) . Nevertheless, it is still controversial whether lymphocytes are targets for IL-19, IL-20, or IL-24. We therefore generated a knockout mouse strain deficient for IL-20R2.
Analysis of the immune system of IL-20R2 Ϫ/Ϫ mice gave no hints of defects in T cell development, but significant functional differences between normal and IL-20R2 Ϫ/Ϫ T cells became evident after polyclonal activation in vitro and Ag-dependent activation in vivo. These results provide strong evidence that IL-20R2 signaling directly influences T cell responses in vivo and in vitro.
In DNA vaccinations prime CD8 answers without the need of adjuvants and inflammation (34) . We chose this model to evaluate the effects of IL-20R2 signaling on CD8 responses in vivo. As expected, we detected significantly higher numbers of Ag-specific CD8 cells in IL-20R2-deficient mice. Further support for enhanced activation of Ag-specific CD8 cells in IL-20R2 Ϫ/Ϫ mice came from analysis of a murine model of contact dermatitis to TNCB. The hypersensitivity reaction to TNCB depends on activated CD8 T cells (31) and was significantly enhanced in IL-20R2-deficient mice.
The number and surface phenotype of CD8, CD4, NK, and NKT cells in IL-20R2 Ϫ/Ϫ mice were undistinguishable from that of wild-type mice. After immunization, the total number of CD4 and CD8 T cells was also comparable between IL-20R2 Ϫ/Ϫ and IL-20R ϩ/Ϫ mice. Thus, it is unlikely that the enhanced Ag-specific CD8 response in IL-20R2 Ϫ/Ϫ mice is due to expanded populations of T cells. We also ruled out that clearance of CD8 cells is inhibited in IL-20R2 Ϫ/Ϫ mice. After vaccination, CD8 cell activation, expansion, and contraction followed the same time course in IL-20R2
Ϫ/Ϫ and IL-20R2 ϩ/Ϫ mice. Maturing human DCs were recently shown to be a source of IL-20 after LPS stimulation (35) , and may strengthen innate responses of epithelial cells. rIL-19 was reported to stimulate IL-10 production in human DCs and to enhance the development of IL-10-producing DC in an in vitro model of DC differentiation (18) . Enhanced Ag-specific CD8 answers after DNA vaccination were previously observed in mice unresponsive to IFN type I (IFN␣␤ receptor Ϫ/Ϫ ) (25) . In contrast to our results, T cell responses were influenced by the genotype of DCs in this model. IL-10 secretion of naive OT II CD4 cells was suppressed, and IFN-␥ secretion was enhanced by Ag-loaded IFN␣␤ receptor Ϫ/Ϫ DC. Thus, we believe that IL-20R2 signaling down-regulates CD8 T cell responses through other mechanisms than type I IFN receptors.
It has recently been shown that CD8 cells lacking IL-10R2 expression undergo enhanced (2-to 3-fold) primary and secondary expansion following Listeria monocytogenes infection (36) . This effect was independent of APCs. Furthermore, it has been reported that IL-10 mediates self-control of Th1 cell expansion after infections with different pathogens (37, 38) . Conventional T-bet ϩ/ϩ animals of C57BL/6 background (generation 10). For the quantification of Ig subtypes, suspension arrays based on xMAP technology were conducted in principle, as described (26) . IL-20R2
Ϫ/Ϫ and IL-20R2 ϩ/ϩ of BALB/c background (generation 12) were analyzed for IgG2a. IgG2a baseline levels were comparable between both mouse strains (data not shown). All xMAP assay measurements were conducted for a minimum of 100 beads per isotype. In addition, IgE levels determined by xMAP assays were verified by a conventional ELISA (BioLegend). One dot represents data from one animal. Bars are set at mean values of each group. Statistical significance of differences in Ig concentrations was analyzed using the Mann-Whitney U test. Values of p Ͻ 0.05 ‫)ء(‬ were considered statistically significant.
It has been reported previously that rIL-19 and rIL-20 polarize naive T cells toward a Th2 phenotype after several rounds of stimulation in vitro (17) . IL-24 is up-regulated in Th2-polarized lymphocyte preparations (19, 20) . rIL-19 enhances the induction of Th2 cytokines in a murine asthma model (14, 39) . In vivo, a shift of Th1 to Th2 answers results in switching of the IgG isotype to higher IgG1/IgG2a ratios (27) ϩ/Ϫ T cell cultures was not sufficient to increase the production of IL-4 and IL-10 above the detection limit of the ELISA. The second reason could be that IL-24 or IL-19, which signals via IL-20R type I, might be responsible for the repression of T cells. In our hands, mIL-19 did not induce STAT3 phosphorylation in cells with endogenous receptor levels, e.g., primary cultures of epithelial skin cells or after s.c. injection in mice. Thus, we could not determine whether IL-20, which binds to both types of IL-20R, or IL-19, which binds only to IL-20R type I, has redundant or different effects on T cells. Our in vivo and in vitro data suggest that IL-19, IL-20, and IL-24 suppress CD4/CD8 T cell responses during priming. They might prepare T cells to aquire Th2-like functions, which may then be sustained by other factors (e.g., IL-4). Because active mIL-19 and IL-24 are not available and the bioreactivity of mIL-20 seems to be low, a detailed analysis of the underlying mechanisms is not possible at the moment.
CD8 T cell responses are especially important for the effective clearance of viruses such as hepatitis B virus, and are necessary to prevent and resolve the development of chronic hepatitis. The regulation of Ag-specific CD8 responses is therefore of major therapeutic interest (41) (42) (43) (44) . In summary, we could show that IL-20R2 regulates T cell activation directly and attenuates Ag-specific CD8 responses. It is tempting to speculate that IL-19, IL-20, and IL-24 have IL-10-like anti-inflammatory activities and might be useful to down-regulate overwhelming immune reactions in chronic diseases.
